-
Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies
Mar 10, 2025, 14:00 PM -
Uncovering the Cost of Red Blood Cell (RBC) and Platelet (PLT) Transfusions in Africa, Asia, Oceania, and the Americas and Exploring Related Implications in a Trial Example
Mar 10, 2025, 14:00 PM -
Knowledge and Willingness to Self-Sampling About Cervical Cancer Screening in Zala County, Hungary
Mar 10, 2025, 14:00 PM -
The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland
Mar 10, 2025, 14:00 PM -
Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction
Mar 10, 2025, 14:00 PM -
Analysis of the Quality of Life of Patients Undergoing Hip Replacement Surgery Using the SF-36 Questionnaire
Mar 10, 2025, 14:00 PM -
Perfect Health Reporting on EQ-5D-5L: The Role of Personal, Family and Social Network Illness Experiences
Mar 10, 2025, 14:00 PM -
A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States
Mar 10, 2025, 14:00 PM -
Tinnitus Risk After XBB.1.5 COVID-19 Vaccination: A Self-Controlled Case Series Study
Mar 10, 2025, 14:00 PM -
Adoption of a Drug Adherence-Enhancing Application To Achieve Optimal Medication Adherence and Blood Pressure Control Among Hypertensive Patients: A Randomized Controlled Trial
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analyses of Repotrectinib in TKI-Naïve Patients with ROS1+ Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization in the Management of Patients with Relapse/Refractory Mantle Cell Lymphoma in Canada
Mar 10, 2025, 14:00 PM -
Comparing Chemotherapy, Monotherapy, and Combination Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer Progression-Free Survival and Overall Survival: Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Assessing the Added Value of Fixed-Dose Combinations in Non-Communicable Diseases: A Comparative HTA Analysis Across Canada, Scotland, France, and Germany (2014-2024)
Mar 10, 2025, 14:00 PM -
The Duration of Medically Necessary Drug Shortages
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization of Tafamidis Patients in the United States
Mar 10, 2025, 14:00 PM -
Evaluation of Epidemiological Disease Burden of Endometriosis Based on Routinely Collected Health Data Between 2010 and 2019
Mar 10, 2025, 14:00 PM -
Out-of-Pocket Health Care Spending Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
Mar 10, 2025, 14:00 PM -
Economic Impact of Implementing a Clinical Protocol and Therapeutic Guidelines for Cow's Milk Protein Allergy in Two States of Brazil
Mar 10, 2025, 14:00 PM
